We recently published a list of 10 Most Profitable Value Stocks to Buy Now. In this article, we are going to take a look at ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than $80 billion in non-COVID revenue by 2030. This represents an increase of ...

Since that time, though, demand for these products has declined, and that's resulted in lower revenue and a drop in the Pfizer share price. Right now, as an investor, you may be wondering if you ...